Sign up to save your podcasts
Or
Share AUA 2025 special: Dr. Neal Shore discusses phase 3 CREST study results
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
AUA 2025 special: Dr. Neal Shore discusses phase 3 CREST study results
At the 2025 American Urological Association (AUA 2025) Meeting in Las Vegas, UROONCO BCa chief editor Dr. Benjamin Pradere (FR) talked to Dr. Neal Shore (US) about the CREST study results: Sasanlimab in combination with bacillus calmette-guérin (BCG) improves event-free survival (EFS) versus bacillus calmette-guérin as standard of care in high-risk non- muscle-invasive bladder cancer (NMIBC).
Dr. Shore explains the study rational, the results of the study, and the take home messages he presented during the meeting.
View all episodes
By European Association of Urology
3.7
33 ratings
At the 2025 American Urological Association (AUA 2025) Meeting in Las Vegas, UROONCO BCa chief editor Dr. Benjamin Pradere (FR) talked to Dr. Neal Shore (US) about the CREST study results: Sasanlimab in combination with bacillus calmette-guérin (BCG) improves event-free survival (EFS) versus bacillus calmette-guérin as standard of care in high-risk non- muscle-invasive bladder cancer (NMIBC).
Dr. Shore explains the study rational, the results of the study, and the take home messages he presented during the meeting.
More shows like EAU Podcasts
View all
Hidden Brain
43,741 Listeners
NEJM This Week
318 Listeners
JAMA Clinical Reviews
499 Listeners
TED Health
1,423 Listeners
White Coat Investor Podcast
2,445 Listeners
Urology Care Podcast
17 Listeners
BJUI - BJU International
1 Listeners
The Zero to Finals Medical Revision Podcast
144 Listeners
The Uromigos
57 Listeners
GU Cast | Urology Podcast
2 Listeners
No Stupid Questions
3,658 Listeners
BackTable Urology
53 Listeners
The Economics of Everyday Things
1,675 Listeners
Urology Times Podcasts
0 Listeners
Campbell's Urology: Expert Insights
3 Listeners